2.93
price up icon1.91%   0.05
 
loading

Genelux Corp Borsa (GNLX) Ultime notizie

pulisher
Apr 18, 2025

Is EUROFINS SCIENT (ERFSF) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Apr 18, 2025
pulisher
Apr 14, 2025

Raymond James Financial Inc. Takes $41,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Apr 14, 2025
pulisher
Apr 08, 2025

Benchmark maintains $25 target on Genelux stock, optimistic on trials - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Benchmark maintains $25 target on Genelux stock, optimistic on trials By Investing.com - Investing.com India

Apr 08, 2025
pulisher
Apr 04, 2025

What is HC Wainwright’s Forecast for Genelux Q1 Earnings? - Defense World

Apr 04, 2025
pulisher
Apr 04, 2025

Analysts Offer Predictions for Genelux Q1 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 01, 2025

Genelux (NASDAQ:GNLX) Given Buy Rating at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Genelux Corp. Buy Rating: Strategic Financial Positioning and Growth Prospects Amid Clinical Advancements - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

H.C. Wainwright maintains Buy on Genelux shares, target at $30 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

H.C. Wainwright maintains Buy on Genelux shares, target at $30 - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

Genelux Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Mar 30, 2025
pulisher
Mar 29, 2025

Brokers Set Expectations for Genelux FY2024 Earnings - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

Research Analysts Set Expectations for Genelux Q1 Earnings - The AM Reporter

Mar 29, 2025
pulisher
Mar 28, 2025

Genelux reports FY24 EPS (95c), consensus (88c) - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

FDA Green Light: Genelux's Cancer Drug Olvi-Vec Advances as 2024 Data Shows 71% Disease Control - Stock Titan

Mar 28, 2025
pulisher
Mar 28, 2025

GENELUX Corp SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Down -29.7% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

Genelux (GNLX) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Promising Clinical Trial Results and Strong Financial Position Justify Buy Rating for Genelux Corp. - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

What is HC Wainwright’s Estimate for Genelux Q1 Earnings? - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Benchmark maintains $25 target on Genelux following trial data - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Genelux’s (GNLX) Buy Rating Reaffirmed at HC Wainwright - Defense World

Mar 26, 2025
pulisher
Mar 26, 2025

Genelux stock holds Buy rating, $30 target from H.C. Wainwright - Investing.com India

Mar 26, 2025
pulisher
Mar 25, 2025

Genelux prices 3M shares at $3.50 in underwritten public offering - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

Genelux, Newsoara announce preliminary Phase 1b/2 data of Olvi-Vec - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

Genelux announces alignment with FDA of approval pathway for Olvi-Vec - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

Genelux Announces FDA Guidance on Olvi-Vec Phase 3 Trial - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

Genelux Prices 3 Mln Stock Offering At $3.50/shr, Stock Fell - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

Genelux's Olvi-Vec Shows Anti-Tumor Effect in Phase 1b/2 Lung Cancer Study - Marketscreener.com

Mar 25, 2025
pulisher
Mar 25, 2025

Genelux Prices $10.5 Million Stock Offering - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

$10.5M Capital Raise: How Genelux Plans to Accelerate Cancer Drug Pipeline - Stock Titan

Mar 25, 2025
pulisher
Mar 25, 2025

Breakthrough: Cancer Drug Achieves 79% Tumor Reduction in Advanced Lung Cancer Study - Stock Titan

Mar 25, 2025
pulisher
Mar 02, 2025

Why Genelux Corporation (GNLX) is Skyrocketing So Far in 2025 - Insider Monkey

Mar 02, 2025
pulisher
Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 28, 2025

D.A. Davidson & CO. Makes New $51,000 Investment in Genelux Co. (NASDAQ:GNLX) - Defense World

Feb 28, 2025
pulisher
Feb 16, 2025

Apollon Wealth Management LLC Grows Stock Holdings in Genelux Co. (NASDAQ:GNLX) - Defense World

Feb 16, 2025
pulisher
Feb 13, 2025

Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth? - simplywall.st

Feb 13, 2025
pulisher
Feb 08, 2025

Genelux Corporation (NASDAQ:GNLX) Announces CFO Transition and Appointment of New CFOGenelux Corporation, a leading biotechnology company, recently disclosed in an SEC filing that Lourie Zak has resigned as Chief Financial Officer, effective imm - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Genelux Corporation Announces Matt Pulisic Serves as Principal Financial Officer and Principal Accounting Officer - Marketscreener.com

Feb 07, 2025
pulisher
Feb 05, 2025

Genelux appoints new CFO as Lourie Zak departs - MSN

Feb 05, 2025
pulisher
Feb 03, 2025

Genelux Corporation Announces New Chief Financial Officer - Markets Insider

Feb 03, 2025
pulisher
Feb 03, 2025

GNLXGenelux Corp Latest Stock News & Market Updates - Stock Titan

Feb 03, 2025
pulisher
Feb 03, 2025

Genelux appoints new CFO amid clinical advancements - Investing.com

Feb 03, 2025
pulisher
Feb 03, 2025

Genelux Corp. Appoints New CFO Amid Leadership Change - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Ex-Arrowhead & Amgen Executive Takes CFO Role at Genelux: Key Details on Strategic Appointment - Stock Titan

Feb 03, 2025
pulisher
Jan 28, 2025

Oncolytic Viruses Market Expected to rise, 2034 | Targovax, Replimune, Genelux Corporation, Candel Therapeutics, DNAtrix, SillaJen, Treovir, Lokon Pharma AB, Istari Oncology, CG Oncology, Amgen - Barchart

Jan 28, 2025
pulisher
Jan 24, 2025

Genelux (GNLX) Stock Price, News & Analysis - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

We Think Genelux (NASDAQ:GNLX) Needs To Drive Business Growth Carefully - Yahoo Finance

Jan 24, 2025
pulisher
Jan 23, 2025

Could Genelux's Olvi-Vec Emerge As A Powerful Tool In The Fight Against Difficult-to-treat Cancers? - RTTNews

Jan 23, 2025
pulisher
Jan 12, 2025

Geode Capital Management LLC Has $749,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Jan 12, 2025
pulisher
Dec 31, 2024

Genelux director Tyree James L sells shares worth $8,511 - Investing.com India

Dec 31, 2024
pulisher
Dec 30, 2024

Genelux director Tyree James L sells shares worth $8,511 By Investing.com - Investing.com Nigeria

Dec 30, 2024
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
Capitalizzazione:     |  Volume (24 ore):